Full-Time
Critical Care Medicine
Neurocritical Care, Associate Professor
Posted on 5/9/2026
Cincinnati Children’s Hospital and Medical Center
10,001+ employees
Pediatric hospital, research, and medical education
No salary listed
Cincinnati, OH, USA
In Person
Occasional assignments at locations outside the Burnet Campus may be required.
 Medical, Clinical & Veterinary (1) |
|---|
- M.D., D.O., or equivalent degree
- Current active medical license issued by the State of Ohio or eligible for license
- Appropriate medical credentialing through the Medical Staff Services offices
- Completion of all required pre-employment activities
- Associate Professor appointment or eligibility required
- Generally requires a minimum of five years of service at the Assistant Professor rank
- Board certification
- Program Leadership: Lead the strategic planning, implementation, and management of a comprehensive neurocritical care program within the PICU.
- Multidisciplinary Collaboration: Work closely with neurology, neurosurgery, emergency medicine, neuroradiology, patient services and rehabilitation teams to develop evidence-based clinical pathways and protocols that optimize outcomes for neurocritical care patients.
- Education & Training: Train PICU faculty, fellows, residents, nurses and other healthcare professionals in the care of children with severe neurologic conditions. Lead educational initiatives, including neurocritical care case reviews and skills development workshops.
- Research: Promote and conduct clinical and translational research in pediatric neurocritical care. Collaborate with institutional research teams to advance knowledge and improve outcomes for children with neurologic injuries and diseases.
- Quality Improvement: Design and lead quality improvement initiatives aimed at enhancing care processes, outcomes, and safety for neurocritical care patients. Develop metrics to assess and monitor program performance and patient outcomes.
- Family-Centered Care: Collaborate with the hospital’s Child Life and Family Services to ensure the provision of family-centered care, emphasizing compassionate communication and comprehensive support for families during critical illness.
- Patient Care: Provide safe, effective and compassionate patient care commensurate with the level of advancement and clinical specialty and make significant contributions to clinical service as evidenced by expertise in clinical care. Develop and maintain local and regional recognition by peers and patients as an authority in the field. Develop clinical skills or programs that are local or regionally distinctive. Applies clinical skills that are clinically sound, effective and achieve exceptional patient outcomes.
- Teaching and Training: Teaches and supervises the patient care of residents, advanced practice nurses, fellows and PICU staff. Serve as a role model within the PICU and Division in mentoring trainees.
- Fellowship training in Pediatric Neurocritical Care, Pediatric Neurology, or significant clinical experience managing neurocritical care patients.
- Experience developing clinical pathways and evidence-based protocols.
- Demonstrated ability to build and lead collaborative teams across disciplines
Cincinnati Children’s Hospital Medical Center provides pediatric healthcare ranging from routine checkups to treatments for rare, complex conditions. The center operates by integrating clinical care with a research-based education system that trains over 600 medical residents and fellows annually. It distinguishes itself from other providers by serving as a major academic department for the University of Cincinnati, combining large-scale medical training with active scientific research. The organization's goal is to improve child health outcomes through a combination of specialized patient care, medical discovery, and the education of future pediatric professionals.
Company Size
10,001+
Company Stage
Grant
Total Funding
$18.4M
Headquarters
Cincinnati, Ohio
Founded
1883
Simplify's Take
What believers are saying
- Mary Bridge collaboration expands cardiology to Pacific Northwest in 2026.
- $50M AI platform launched March 2026 cuts emergency waits by 25%.
- SURF program trains 100 undergraduates yearly, 90% enter biomedical careers.
What critics are saying
- Liberty Campus urgent care waits average 128-143 minutes, losing patients to Nationwide.
- Burnet Campus overloads capacity, eroding market share in 3-6 months.
- Atla-cel fails Phase 2 pediatric trials in 12-24 months, sparking lawsuits.
What makes Cincinnati Children’s Hospital and Medical Center unique
- BioOra partnership advances Atla-cel CAR-T with reduced neurotoxicity for pediatric leukemia.
- Ranks #3 in U.S. News 2024-2025 Honor Roll, #1 in cancer and cardiology.
- Genetic Base identified 1,000 new gene-disease associations since 2020.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
401(k) Retirement Plan
Tuition Reimbursement
Employee Discounts
Wellness Program
Relocation Assistance
Company News
BioOra and Cincinnati Children's Hospital Medical Center have partnered to advance Atla-cel, a third-generation CAR-T therapy, for children with relapsed or refractory B-cell acute lymphoblastic leukaemia. The collaboration builds on adult clinical data showing markedly reduced neurotoxicity compared to earlier CAR-T therapies. Atla-cel demonstrated low rates of immune effector cell-associated neurotoxicity syndrome in the Phase 1 ENABLE-1 adult study, positioning it as a compelling candidate for paediatric use where neurotoxicity poses heightened developmental risks. The reduced toxicity could enable outpatient delivery, eliminating prolonged hospital stays. Cincinnati Children's will lead a global clinical programme enrolling patients across the United States, New Zealand and potentially Australia. Dr Stella Davies will serve as principal investigator. As part of the partnership, Cincinnati Children's CEO Steve Davis joins BioOra's board.
Life-saving cancer treatment facility to create 1100 jobs. A new manufacturing facility in the city will deliver CAR-T cell immunotherapy, which uses a patient's own immune cells to identify and attack cancer cells. PHOTO: LONZA AG Pioneering cancer treatment company BioOra will offer a life-saving cancer therapy when its new immunotherapy manufacturing facility opens in October. The high-tech facility at Te Papa Hauora Health Precinct on Oxford Tce will increase development of CAR-T cell immunotherapy, a cancer treatment that uses a patient's own immune cells. Economic development agency ChristchurchNZ estimated the base will generate about $98 million to the economy from treating about 500 patients each year. This came a step closer at a site blessing attended by clinicians, international experts, investors, industry representatives and civic leaders. BioOra chief executive John Robson said Christchurch stood out in the site selection process because of its hospital, health precinct and other facilities. He said the goal was to bring potentially curable treatments to patients who had at this stage limited or no other options. "What we're developing has real curative potential, particularly for cancers like lymphoma. "This is about bringing a level of treatment to New Zealand that has, until now, largely only been available overseas." Ministry of Health chief science advisor Ian Town said the city was playing an important role in advanced cancer therapies. "Christchurch is positioning itself as a leading centre for cancer research and treatment. Having international experts here today reinforces that reputation. These innovative therapies are the future of cancer care in New Zealand." Robson said ChristchurchNZ helped connect BioOra to the right people, talent and infrastructure. ChristchurchNZ chief executive Ali Adams said BioOra's decision to move into Oxford Tce shows the city is attracting world-class health innovations that can be scaled up and succeed. "This facility represents confidence in Christchurch's ability to support science that genuinely changes lives," she said. BioOra will develop clinical trials and carry out therapies seldom available globally at the facility, and partner with Cincinnati Children's Hospital Medical Center, which is a global leader in paediatric CAR-T therapy. The United States' hospital's bone marrow transplantation and immune deficiency division director, Dr Stella Davies, said the therapies are "genuinely" revolutionary. "CAR-T can work much more rapidly, with early remission occurring in as little as 28 days - a dramatically improved experience for patients and their families." BioOra is a private joint venture between the Malaghan Institute of Medical Research and Bridgewest Ventures NZ LP. Malaghan trust board member David Downs went overseas for CAR-T therapy eight years ago, and said watching the facility become a reality in New Zealand was emotional. Once operational, it is expected to support about 1100 jobs in healthcare, manufacturing, tourism and other services, including more than 480 direct roles. The BioOra facility is expected to open on October 7.
GBBN wins Healthcare Environment Award. At the new Cincinnati Children's William K. Schubert M.D. Mental Health Center, a 97% reduction in restraint and seclusion hours isn't just a statistic - it's proof that when design supports an innovative care plan, it positively impacts lives. GBBN is honored that the Center for Health Design recognized this project with a 2026 Healthcare Environment Award. The growing pediatric mental health care crisis in America increases the need for spaces that destigmatize and demystify treatment. The William K. Schubert M.D. Mental Health Center fills a critical gap by expanding access to care through a building that sends a potent message: Help, hope, and health are within reach. The largest pediatric inpatient behavioral hospital in the U.S., this facility used salutogenic and evidence-based strategies to develop an advanced care model embodied in the landscape, architecture and interior design. GBBN Architects collaborated with Cincinnati Children's Hospital Medical Center to re-think the collection of therapeutic settings known as milieu. These are the spaces where patients spend most of their time, participating in group therapy, guided activities, free choice time, and other therapies. The building's design was influenced by the location and variety of milieu spaces on the units within the building and their role as shared resources and destinations. Also integral to the design was the childhood act of building a blanket fort - an intuitive gesture of creating shelter, imagination and control. Gentle curves, layered transparency and organic shapes give the building a sense of security and softness. Natural wood, textured surfaces and color-shifting dichroic glass fins evoke playfulness and discovery, making the building feel both new and familiar. That softness extends inside. A light-filled lobby with an oculus conveys hope; cozy nooks built into the walls offer prospect and refuge; interior columns invite touch; clear sightlines to the Family Resource Center and café help visitors orient quickly, bringing a sense of calm. At night, the building glows from within - lantern-like, a beacon in the landscape, like light peeking through a blanket fort. GBBN Architects partnered with researchers at Clemson University for the Post Occupancy Evaluation (POE) of this new facility. The POE was the inaugural project helping to structure Cincinnati Children's behavioral health toolkit. "This project includes many features that are groundbreaking in behavioral health environments," explains Angela Mazzi, who was part of GBBN's project design team. "These innovations include private rooms, no nurse stations, and an unprecedented amount and variety of milieu space. The project also features greenspace for both play therapy and horticultural therapy." Jurors praised the project's clear design vision, innovative care model, and thoughtful organization of therapeutic spaces, noting strong research that continued through post-occupancy - and the warm, welcoming, child-friendly environment that gives patients flexibility in their care. See more of its work with Cincinnati Children's here, here and here. See more of its healthcare projects here.
Cincinnati Children's and MultiCare Mary Bridge Children's have launched a collaboration to expand access to paediatric cardiology and complex heart surgery in the Pacific Northwest. The partnership brings Cincinnati Children's Heart Institute's expertise to Tacoma, Washington, enabling patients to receive care closer to home. Mary Bridge Children's Heart Center will recruit top talent and work with Cincinnati Children's on medical decision-making, education and quality improvement programmes. The collaboration includes joint case reviews involving surgeons, cardiologists and specialists, focusing on shared decision-making and best practices. Mary Bridge Children's recently hired Jorge Salazar as executive medical director and chief cardiac surgeon. The Heart Center is accepting new patients and will open a dedicated clinic in spring 2026. Cincinnati Children's maintains similar collaborations with hospitals in Kentucky, Ohio and Indianapolis.
Cincinnati Children’s will expand primary care options in Warren County by adding Springboro Pediatrics as a neighborhood location.